Article
Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Nov 2004
Robien Kim, Ulrich Cornelia M, Bigler Jeannette, Yasui Yutaka, Gooley Ted, Bruemmer Barbara, Potter John D, Radich Jerald P
Abstract excerpt
PURPOSE: Methylenetetrahydrofolate reductase (MTHFR) directs intracellular folate toward homocysteine metabolism and away from nucleotide synthesis. Two common MTHFR polymorphisms, C677T and A1298C, are associated with reduced enzyme activity. We evaluated the association of these polymorphisms with risk of relapse and bcr-abl mRNA transcript detection among 336 Caucasian patients who underwent allogeneic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
